ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, activation of STAT3 or STAT5 via a JAK‐dependent but BCR‐ABL‐independent pathway promotes IM resistance of CML cells in BM microenvironment models.28, 37, 38